Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of human bronchial epithelial cells treated with cigarette smoke and mycobacteria

ABSTRACT: Exposure to cigarette smoke (CS) is a known risk factor for pulmonary tuberculosis, and smokers are at increased risk of treatment failure and relapse. Using differentiated primary human bronchial epithelial cells (PBEC), we studied whether there is a direct effect of acute CS exposure on epithelial host responses to infection with Mycobacterium tuberculosis (Mtb) and Mycobacterium avium (Mav). The study population included 8 individual donors, of whom 4 were female. Median age was 66.5 years (range 56-70). Of these donors, none were current smokers, 5 were ex-smokers (62.5%), 2 were non-smokers (25%) and no information was available for 1 donor (12.5%). None of the donors were diagnosed with chronic obstructive pulmonary disease.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Amy Barclay

PROVIDER: E-MTAB-17246 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Transcription profiling by array to investigate effect of repeated cigarette exposure on three-dimensional human bronchial epithelial cultures

Project description:Cigarette smoke (CS) is a major risk factor in the development of chronic inflammatory lung diseases such as chronic obstructive pulmonary disease. To evaluate the biological impact of CS on lung tissue, three-dimensional (3D) organotypic bronchial tissue cultures can be used to replicate in vivo conditions. We developed an original 3D human bronchial epithelial co-culture model to assess the biological impact of repeated CS exposure on cell differentiation and on the inflammatory response. We found that CS can disrupt homeostatic capacity in a dose-dependent manner, and that the activation of the EGFR pathway, which is involved in the early-stage pathogenesis of airway diseases, was predicted from transcriptomic data. We believe that our model of bronchial tissues, used for repeated CS exposure, can provide valuable information on tissue-specific alterations in biological systems.

2018-09-30 | E-MTAB-6175 | biostudies-arrayexpress

Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infection

Project description:Type I interferons (IFN-I) exert pleiotropic biological effects during viral infections, balancing virus control versus immune-mediated pathologies and have been successfully employed for the treatment of viral diseases. Humans express twelve IFN-alpha (α) subtypes, which activate downstream signalling cascades and result in distinct patterns of immune responses and differential antiviral responses. Inborn errors in type I IFN immunity and the presence of anti- IFN autoantibodies account for very severe courses of COVID-19, therefore, early administration of type I IFNs may be protective against life-threatening disease. Here we comprehensively analysed the antiviral activity of all IFNα subtypes against SARS-CoV-2 to identify the underlying immune signatures and explore their therapeutic potential. Prophylaxis of primary human airway epithelial cells (hAEC) with different IFNα subtypes during SARS-CoV-2 infection uncovered distinct functional classes with high, intermediate and low antiviral IFNs. In particular IFNα5 showed superior antiviral activity against SARS-CoV-2 infection. Dose-dependency studies further displayed additive effects upon co-administered with the broad antiviral drug remdesivir in cell culture. Transcriptomics of IFN-treated hAEC revealed different transcriptional signatures, uncovering distinct, intersecting and prototypical genes of individual IFNα subtypes. Global proteomic analyses systematically assessed the abundance of specific antiviral key effector molecules which are involved in type I IFN signalling pathways, negative regulation of viral processes and immune effector processes for the potent antiviral IFNα5. Taken together, our data provide a systemic, multi-modular definition of antiviral host responses mediated by defined type I IFNs. This knowledge shall support the development of novel therapeutic approaches against SARS-CoV-2.

2022-02-09 | PXD026079 | Pride

Utilizing a bioartificial 3D bronchial epithelial airway model to study lunar hay fever on Earth

Project description:This study underscores the urgent need to understand how lunar regolith dust affects human health, an issue critical for sustaining long-term human presence on the Moon. Past Apollo missions, revealed that lunar dust exposure can trigger allergy-like symptoms, suggesting a biological reactivity that is still poorly understood. Using a 3D human airway model that closely mimics real bronchial tissue, researchers found that lunar regolith simulant (JSC-1) causes unique and early physiological changes that differ significantly from responses to Earth-based dust (PM10). The distinct effects of lunar regolith on mucociliary clearance, barrier integrity, and airway remodeling suggest that cellular and molecular pathways are being activated or suppressed in ways not seen with terrestrial particles. Proteomics can uncover which specific proteins are altered during exposure, providing insight into the mechanisms of toxicity, stress response, and long-term adaptation or damage. Moreover, the data reinforces that terrestrial dust studies are not directly translatable to the lunar context. Therefore, proteomic profiling specific to lunar dust exposure is not just beneficial, it's necessary to develop targeted medical countermeasures, design safer habitats, and support the health of future lunar explorers.

2026-04-10 | PXD064375 | Pride

New validated reference genes for gene expression studies in the differentiating human airway epithelium

Project description:The aim of this study was to identify stably expressed genes suitable for RT-qPCR normalization in an in vitro model of human airway epithelium (AE). RNA sequencing was performed to characterize global gene expression profiles across AE cultures representing various sexes, AE origin (bronchial or nasal) and stages of epithelial differentiation. Strand-specific poly(A)-selected libraries were prepared using the TruSeq Stranded mRNA protocol and sequenced at Macrogen Europe BV (Amsterdam, Netherlands) on the Illumina NovaSeq 6000 platform in paired-end mode (2 × 150 bp), generating approximately 100 million reads per sample. The deposited files include raw paired-end FASTQ data generated from 2 primary and 27 human AE cells differentiated in vitro in ALI (air-liquid interface) culture. These data were used for transcriptome-wide assessment of gene expression stability and selection of candidate reference genes for downstream validation.

2026-05-11 | E-MTAB-16674 | biostudies-arrayexpress

COVID-19 patients show sustained systemic hyaluronan and a 3D infection lung model reveals the mechanism behind SARS-CoV-2 overproduction of hyaluronan, which is counteracted by cortisone treatment

Project description:RNAseq of primary fibroblasts in a air-lung-interface model, with and without corticosteroid treatment

2023-09-29 | E-MTAB-12368 | biostudies-arrayexpress

Transcription profiling of human normal human bronchial epithelial (NHBE) cells exposed to whole cigarette smoke over a time series to study the impact of tobacco exposure

Project description:Gene expression patterns were assessed in normal human bronchial epithelial (NHBE) cells exposed to cigarette smoke (CS) from a typical "full flavor" American brand of cigarettes in order to develop a better understanding of the genomic impact of tobacco exposure, which can ultimately define biomarkers that discriminate tobacco-related effects and outcomes in a clinical setting. NHBE cells were treated with CS for 15 minutes and alterations to the transcriptome assessed at 1,2,4 and 24 hours post-CS-exposure using high-density oligonucleotide microarrays. Experiment Overall Design: Cells were exposed to smoke or air (âmock-exposedâ) for 15 min, after which they were refed with fresh media and allowed to incubate for 1h, 2h, 4h or 24h. Smoke and mock samples were compared at each time point.

2008-04-06 | E-GEOD-10718 | biostudies-arrayexpress

Concurrent jamming and mesenchymal-to-epithelial transitions during airway basal stem cell differentiation

Project description:During differentiation of human airway basal stem cells, the confluent epithelium undergoes a phase transition from a fluid-like migratory unjammed phase to a solid-like stationary jammed phase. While mechanisms underlying this process, termed the jamming transition, remain poorly understood, here we demonstrate that the jamming transition coincides with the mesenchymal-to-epithelial transition (MET) during epithelial differentiation. Both the jamming transition and MET are delayed in airway basal stem cells cultured from asthmatic donors, a phenotype which can be recapitulated or abrogated through manipulation of TGF-β receptor activation.

2025-11-25 | E-MTAB-16209 | biostudies-arrayexpress

Systems biology approaches reveal low-dose effects of nanoparticles

Project description:Here, we show that systems biology approaches can uncover mechanisms underlying cellular responses to nanomaterials. Using RNA Seq, we found that cationic nanoparticles are capable of triggering down-regulation of cell cycle-related genes in primary human bronchial epithelial cells at doses that do not elicit acute cytotoxicity. Bioinformatics analyses implicated NF-kappaB as a putative transcriptional regulator and functional assays confirmed that cationic nanoparticles caused NF-kappaB-dependent cell cycle arrest. Our study demonstrates the feasibility of applying systems biology tools to assess cellular responses to nanomaterials, not least at low doses.

2015-01-17 | E-MTAB-2397 | biostudies-arrayexpress

RNA-seq analysis of bronchosphere cultures of primary human bronchiolar epithelial cells

Project description:Primary human bronchial epithelial cells were transduced with control or hYAP(S127A) lentivirus in sphere forming conditions. Bronchospheres were harvested on day 18-20 for RNAseq analysis Passage 1 Primary HBECs from 2 independent donors were transduced with control or hYAP lentivirus. 48 hours post infection, cells were plated on transwell inserts in a 50-50 mixture of ALI medium-Cultrex BME reduced growth factor (RGF) to form spheres. Well differentiated bronchospheres were harvested for RNA-seq analysis on day 18-20 by combining 3 wells of each group for each donor.

2015-01-01 | E-GEOD-61626 | biostudies-arrayexpress

Bulk RNA-seq of an ALI (Air-lung interface) model of SARS-CoV2

Project description:This dataset looks at the transcriptome of in vitro-differentiated primary lung cells infected with SARS-CoV2. Some cells have been treated with the drug Enzalutamide.

2022-05-04 | E-MTAB-10687 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data